QuantumPharm, Inc. (HK:2228) has released an update.
QuantumPharm Inc. has announced the updated roles and functions of its board of directors, effective October 30, 2024. The board comprises both executive and independent non-executive directors, who will serve on various committees, including audit, remuneration, and nomination. This restructuring aims to enhance governance and strategic oversight as the company continues to navigate the financial markets.
For further insights into HK:2228 stock, check out TipRanks’ Stock Analysis page.